WIXOM, Mich. , June 22, 2022 /PRNewswire/ Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that
Form 8-K ROCKWELL MEDICAL, INC For: Jun 16 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Rockwell Medical, Inc. (NASDAQ:NASDAQ:RMTI) Q1 2022 Earnings Conference Call May 16, 2022 16:15 ET Company Participants Jason Finkelstein - Investor Relations Russell Ellison - President.
- First quarter net sales of $16.1 million, up 4.2% year-over-year - - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home.